What is anaphylaxis

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Here is a comprehensive overview of anaphylaxis based on authoritative emergency medicine textbooks:

Anaphylaxis

Definition

Anaphylaxis is a serious, rapid-onset allergic reaction that may cause death and requires emergent diagnosis and treatment. It is now used as a single term to describe both IgE-dependent (previously "anaphylactic") and IgE-independent (previously "anaphylactoid") reactions, because the final pathway in both is identical. It represents the most severe form of immediate hypersensitivity. — Tintinalli's Emergency Medicine, p. 110

Pathophysiology

Anaphylaxis arises primarily from activation of mast cells and basophils through crosslinking of IgE and aggregation of high-affinity IgE receptors. Upon activation, these cells rapidly release:
  • Preformed mediators: histamine, tryptase, carboxypeptidase A, proteoglycans
  • Newly synthesised mediators: prostaglandins, leukotrienes, platelet-activating factor (via arachidonic acid cascade)
  • Cytokines: TNF-α (released both early and late)
Effects of key mediators:
MediatorEffect
HistamineVasodilation, ↑ vascular permeability, ↑ heart rate, bronchoconstriction
Prostaglandin D₂Bronchoconstriction, pulmonary/coronary vasoconstriction, peripheral vasodilation
LeukotrienesBronchoconstriction, ↑ vascular permeability, airway remodeling
Platelet-activating factorPotent bronchoconstriction, ↑ vascular permeability
TNF-αNeutrophil activation, chemokine synthesis
Tintinalli's Emergency Medicine, p. 110

Common Triggers

  • Foods: peanuts, tree nuts, shellfish, milk, eggs, soy, mammalian meats (alpha-gal sensitization after tick bite)
  • Medications: antibiotics (especially penicillins), NSAIDs, radiocontrast media
  • Insect stings: hymenoptera venom (bees, wasps, ants) — occurs in up to 3% of adults stung
  • Latex: natural rubber latex (NRL) — still common in many countries
  • Allergen immunotherapy injections
  • Idiopathic (no cause identified) — a significant proportion
NSAIDs are the most common trigger of drug-induced anaphylaxis, acting through non-IgE (arachidonic acid) mechanisms. — Rosen's Emergency Medicine, p. 2386

Clinical Features

The classic progression:
  1. Early: pruritus, cutaneous flushing, urticaria
  2. Developing: throat fullness, anxiety, chest tightness, shortness of breath, lightheadedness
  3. Severe: hoarseness/"lump in throat" (laryngeal edema), respiratory distress, hypotension, decreased consciousness
  4. Associated symptoms: abdominal pain, nausea, vomiting, diarrhea, bronchospasm, rhinorrhea, conjunctivitis

Diagnostic Criteria (Clinical)

Anaphylaxis is highly likely when any one of the following three criteria is met:
  1. Acute-onset skin/mucosal involvement (urticaria, itching, flushing, or edema) plus either respiratory compromise or reduced blood pressure/end-organ dysfunction
  2. Two or more of the following after exposure to a likely allergen: skin/mucosal involvement, respiratory compromise, reduced BP or shock symptoms, or persistent GI symptoms
  3. Reduced BP after exposure to a known allergen for that patient
Tintinalli's Emergency Medicine, p. 111

Risk Factors

For having anaphylaxis:
  • Pregnant women, infants, teenagers, elderly
  • Parenteral > oral route of allergen exposure
  • History of atopy, mastocytosis
  • Emotional stress, acute infection, physical exertion
  • Summer/fall seasonality
For increased severity and mortality:
  • Cardiovascular or pulmonary disease (especially poorly controlled asthma)
  • Beta-blockers and ACE inhibitors (impair compensatory response)
  • Previous anaphylaxis episode
  • Upright posture at onset
  • Delayed epinephrine administration
Rosen's Emergency Medicine, p. 2386

Treatment

First-Line (Immediate)

Epinephrine (adrenaline) — the cornerstone of treatment
  • IM injection into the anterolateral thigh: 0.3–0.5 mg (0.3–0.5 mL of 1:1000) in adults; 0.01 mg/kg in children (max 0.5 mg)
  • Repeat every 5–15 minutes as needed
  • IV epinephrine infusion for shock refractory to IM dosing
  • Delays in giving epinephrine worsen outcomes — administer immediately
Positioning:
  • Supine (or Trendelenburg) with legs elevated if hypotensive
  • Semi-recumbent if respiratory distress
  • Avoid upright posture
Airway:
  • Supplemental oxygen; early intubation for laryngeal edema (can be very difficult)
IV Fluids:
  • 1–2 L isotonic crystalloid bolus (10–20 mL/kg in children) for distributive shock

Second-Line Agents

AgentUse
Corticosteroids (methylprednisolone 80–125 mg IV; hydrocortisone 250–500 mg IV)Prevent protracted and biphasic reactions
H1 antihistamines (diphenhydramine 25–50 mg IV/IM)Adjunct — symptom relief
H2 antihistamines (ranitidine)Severe cases with circulatory shock
Inhaled β₂ agonists (albuterol)Bronchospasm/wheezing
Vasopressors (dopamine, norepinephrine, vasopressin)Shock refractory to epinephrine
GlucagonAnaphylaxis in patients on beta-blockers (overcomes epinephrine resistance)
IV magnesium sulfateSevere bronchospasm refractory to albuterol
Tintinalli's Emergency Medicine, pp. 111–113

Biphasic Anaphylaxis

A second wave of anaphylaxis can occur hours after the initial reaction without re-exposure to the trigger. Severe initial reactions and need for repeated epinephrine doses are risk factors. All patients should be observed after treatment. — Miller's Anesthesia, p. 1278

Epidemiology

  • Lifetime individual risk: 1%–3%
  • Incidence: ~50–2,000 episodes per 100,000 person-years
  • Fatality: 0.7%–2% per case
  • Fatal anaphylaxis represents <1% of all cases, but medication-induced fatalities are increasing
Washington Manual of Medical Therapeutics; Rosen's Emergency Medicine

Key takeaway: Epinephrine is the only life-saving drug in anaphylaxis — antihistamines and corticosteroids are adjuncts. Early IM epinephrine is the single most important intervention.
This is a shared conversation. Sign in to Orris to start your own chat.